Is Invokana Worth the Risk?
If consumers knew every side effect before taking a drug, would they still choose to take it? What people are unaware of is that they aren’t being told the side effects. Manufacturers conceal them or the FDA identifies potential risks but approves the drugs anyway. This happened with the Type 2 diabetes medication, Invokana. What
Read More
Hundreds of Fosamax Fracture Cases Reinstated
This week the Third Circuit Court of Appeals decided to reverse a ruling by U.S. District court Joel Pisano. Judge Pisano dismissed all federal court Fosamax cases on federal preemption grounds. The Third Court decided that whether the FDA would have rejected a Fosamax label change by the manufacturer, Merck to warn consumers about an
Read More
IVC Filter Lawsuits Mounting
Around 2,000 IVC filter lawsuits are now pending against manufacturer C.R. Bard in a multidistrict ligation (MDL No.2641). This MDL is located in the U.S. District Court for the District of Arizona. It surrounds consumers being injured by serious design flaws caused by the filter. IVC Filters are supposed to prevent deadly blood clots from
Read More
The Michael Brady Lynch Firm Releases Four Part Expose on Taxotere
Thousands of cancer survivors along with Winter Park-based law firm, The Michael Brady Lynch Firm are teaming up to fight against Sanofi-Aventis, the manufacturer of the common chemotherapy drug, Taxotere. Sanofi knew Taxotere brought terrible side effects to cancer survivors. Instead of informing the public, they made strides to hide the results to their American
Read More
Safer Alternatives to Taxotere
Taxotere manufacturer, Sanofi-Aventis knew that their chemotherapy drug could cause permanent hair loss back in the 1990s. The company disclosed to other countries this side effect, but they hid it from patients in the United States. Instead of protecting consumers, they protected their bottom line, especially knowing there are safer alternatives on the market.
Read More
Generic Taxotere Lawsuits Allowed in MDL
The U.S. Judicial Panel on Multidistrict Litigation (JPML) allowed claims revolving around the generic form of Taxotere (docetaxel) to be included in the current Taxotere MDL being tried in the Eastern District of Louisiana. Currently, there are almost 800 lawsuits pending in the MDL. Current Litigation The lawsuits accuse Taxotere manufacturer, Sanofi-Aventis and other
Read More
Why Does Taxotere Cause Permanent Hair Loss?
Chemotherapy-induced hair loss (alopecia) is a side effect many breast cancer patients understand is a distinct possibility. However, they believe the alopecia only occurs during treatment. After chemotherapy and remission, survivors look forward to hair regrowth, a visible sign of recovery. Tragically, for many, they will never grow hair again after using chemotherapy drug, Taxotere.
Read More
Taxotere Manufacturer Hid Side Effect of Permanent Hair Loss
One in eight women will be diagnosed with breast cancer. This equates to almost 300,000 U.S. women every year. Almost 75% of these women will use Taxotere to battle their cancer. But, they were never told there is a chance that by using Taxotere, they could always look like a cancer patient. Taxotere, manufactured by
Read MoreMichael Brady Lynch Lecturers on Pradaxa, Xarelto and Eliquis Cases
Attorney Michel Brady Lynch, Esq. of The Michael Brady Lynch Firm in Winter Park spoke on March 11th in Ft. Lauderdale for Mass Torts Nexus on the subject Anticoagulant Uncontrollable Bleeding Litigation: Pradaxa, Xarelto and Eliquis. Mr. Lynch also spoke on March 16th in Orlando at the Ritz-Carlton Grande Lakes for HB Litigation Conferences: Mass
Read More
Viberzi Increases Pancreatitis Risk
After two patients without a gallbladder died while taking the irritable bowel syndrome drug, Viberzi, the FDA warns all users about an increased risk of serious pancreatitis while on the medication. An FDA review found patients, especially without a gallbladder, have an increased risk of developing serious pancreatitis that could result in hospitalization or death.
Read More